Experience spans several crucial customer-facing roles - Office-Based Clinic Sales (Gastroenterology, Hepatology, Cardiology and Psychiatry), Hospital Sales, and Corporate Account Director role
Significant launch experience - 7 products over the past 15 years
Strong collaborative experience within a matrix environment
Overview
23
23
years of professional experience
Work History
Key Account Manager - Rare Emergency Medicine
Serb Pharmaceuticals
12.2024 - Current
Responsible for selling and differentiating the value of Serb's portfolio of antidotes (CroFab-snake envenomation, DigiFab-digoxin toxicity, Cyanokit-cyanide poisoning, Aurlumyn-severe frostbite) to Rare Emergency Medicine customer groups and individual decision makers
Work closely with Inside Sales, Marketing, HR, Training and Sales Operations
Establish and maintain professional relationships with targeted opinion leaders and hospitals, including pharmacy, surgeons and other critical medical staff
Corporate Account Director
Bioxcel Therapeutics
11.2023 - 11.2024
Promoted to CAD as a result of Hospital sales experience and superior results as a Bioxcel Institutional Specialist
Hybrid position combining Hospital sales, Long-term Care sales and Contracting
Accountable for building targeted Health System and IDN system-wide awareness, advocacy, formulary access and pull-through for Igalmi (a sublingual film for the acute treatment of agitation)
Collaborate cross functionally with Commercial Leadership, Medical Affairs and Market Access to profile large systems, identify access pathways, and develop business plans that open approval for Igalmi utilization
Work with Director of Pricing and Contracting to initiate and pull through a Direct Tiered Pricing Program and GPO Pricing initiatives with hospital systems
Institutional Specialist
Bioxcel Therapeutics
04.2022 - 10.2023
Responsible for navigating complex and multi-layered Hospital accounts for a start-up Biotech organization
Utilized Account Management Skills to successfully launch and pull through a new medication, Igalmi (a sublingual film indicated for the acute treatment of agitation), to health care providers in multiple settings—IDNs, Acute Care Hospitals, Private Psych Hospitals and State Hospitals
Engaged with staff and decision-makers in the Psychiatry Service, Emergency Dept, ICU, Hospital Medicine Dept, Residency Program and Pharmacy
The entire salesforce was dissolved in October 2023
Sales Results:
2023 Ranked 1 out of 70 No President's Club
2022 Ranked 3 out of 26 President's Club Winner
Senior Institutional Account Manager
Salix Pharmaceuticals
09.2017 - 04.2022
Responsible for maximizing sales of life-changing Gastroenterology-focused products (Xifaxan for hepatic encephalopathy and Relistor for opioid-induced constipation) by partnering with decision-makers in key institutions and Specialty Clinics
Accountable for changing the paradigm in the treatment of opioid-induced constipation. Engaged GIs/Hepatologists, Oncologists, Emergency Medicine, Hospitalists and Surgeons with Relistor (a subcutaneous injection that targets OIC)
Accountable for developing Discharge Centers of Excellence for Xifaxan by engaging Hepatologists, Gastroenterologists, Emergency Medicine, Hospitalists, Surgeons, Residents/GI Fellows, Nurses, Case Managers, Clinical Pharmacists, and C-Suite executives
Responsible for providing complex and technical information to ensure appropriate use of Nuedexta for pseudobulbar affect to Psychiatrists, Psych NPs and other healthcare professionals in a Clinic setting
Sales Results:
2017 Q3 (July-Aug) — Ranked 2/45
2017 Q2 — Ranked 16/45 (started 42/45)
Executive Cardiovascular Account Specialist
Lilly, USA
04.2014 - 03.2017
Responsible for representing Lilly, USA, as an industry-leading cardiovascular disease state, market, and product specialist with key Hospitals and office-based cardiology specialists
Maximized sales of Effient (a P2Y12 platelet inhibitor) in the hospital and office setting by managing patient, product, and dollar flow for the ACS-PCI market
Supported Lilly-insulin hospitals with Diabetes resources. Helped to create discharge protocols designed to keep patients on humalog
Accountable for developing action plans that linked to key account goals and priorities with appropriate overlap coordination
Sales Results:
2016 Top 1/3 Portfolio Performance (Effient TRx, Insulin)
2015 Top 1/3 Portfolio Performance (Effient DDD, Effient TRx, Insulin)
Responsible for the launch of several CNS products (Zyprexa, Zyprexa IM, Zyprexa Zydis, Zyprexa Relprevv, Symbyax, Cymbalta, Strattera) in the Dallas Territory
Added all products to hospital formularies
Used a business ownership/Strategic Account Management focus to build productive relationships with Prescribers (Psychiatrists, ED Physicians, Psych Residents, Internists, PCPs, Geriatric Psychs, NPs, PAs), Treatment Teams, Community Mental Health Clinics, State Hospitals, Psych Hospitals, Community Hospitals, Teaching Hospitals, VA Hospitals and LTC Facilities